| Dr Thomas Anthony Gordon, DDS | |
|
8605 Camino Media, Suite. 100, Bakersfield, CA 93311-1355 | |
| (661) 664-1814 | |
| (661) 664-0129 |
| Full Name | Dr Thomas Anthony Gordon |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 8605 Camino Media, Bakersfield, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114092699 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 23506 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Anthony Gordon, DDS 8605 Camino Media, Suite. 100, Bakersfield, CA 93311-1355 Ph: (661) 664-1814 | Dr Thomas Anthony Gordon, DDS 8605 Camino Media, Suite. 100, Bakersfield, CA 93311-1355 Ph: (661) 664-1814 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
Motivated by the lack of treatment options for patients with antiphospholipid syndrome, rheumatology researchers convened an international committee to address the problem directly.
Today, the Centers for Disease Control and Prevention (CDC) is revising the current Global Testing Order to shorten the timeline for required testing for all international air travelers to one day before departure to the United States.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has received a letter from NASDAQ Global Market exchange confirming that, with the appointment of Tamar Howson to the Company's audit committee, as detailed in the Company's Form 8-K filed on April 5, 2010, NASDAQ staff has determined that the Company complies with Listing Rule 5605(c)(2)
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).
› Verified 6 days ago
Sarah Kim, Dentist Medicare: Not Enrolled in Medicare Practice Location: 3990 Ming Ave, Bakersfield, CA 93309 Phone: 661-323-1111 | |
Wasfi Fouad Salama, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1830 28th St, Bakersfield, CA 93301 Phone: 661-326-8536 Fax: 661-326-8511 | |
Dr. Rafaela Pauletto Szpoganicz, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3615 Stockdale Hwy, Suite 2, Bakersfield, CA 93309 Phone: 661-456-0111 Fax: 661-829-4329 | |
Kathleen Marie Ihlendorf Rolfes, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1405 Commercial Way Ste 140, Bakersfield, CA 93309 Phone: 661-404-4063 | |
Dr. Jessica Anne Mahlmann, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3401 Coffee Rd, Bakersfield, CA 93308 Phone: 661-695-3044 | |
Dr. Michel Issa, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4221 S H St, Bakersfield, CA 93304 Phone: 661-200-0983 | |
Charles L Edwards, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5509 Young St, Bakersfield, CA 93311 Phone: 661-664-6104 |